In the fight against Alzheimer's, researchers have developed a promising, preventative therapeutic approach. They specifically targeted the amyloid beta biomolecule, which triggers the hyperactivity of nerve cells typical of the brain disease in its early stages. They succeeded in developing and using a protein drug that can suppress the effects of the harmful molecule.